Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Oxime/Methoxime by Bodor Laboratories for Unspecified Ophthalmological Disorders: Likelihood of Approval
Oxime/Methoxime is under clinical development by Bodor Laboratories and currently in Phase II for Unspecified Ophthalmological Disorders. According to GlobalData,...